Oral Salt and Water to Prevent Contrast Nephropathy

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

June 30, 2016

Conditions
Acute Kidney Injury
Interventions
DRUG

Intravenous Saline

Patients randomized to this arm will receive intravenous isotonic (0.9%) saline. The rate of isotonic saline will be 3 mL/kg given the one hour before CT and 1 mL/kg/hour for 6 hours post-CT as per Canadian guidelines. Patients weighing more than 110 kg will receive the rate as per a 110 kg patient. The dose will be rounded up to the nearest 5 mL.

BIOLOGICAL

Oral Salt and Water

Oral salt capsules and water, based on patient weight

Trial Locations (1)

K1H7W9

Ottawa Hospital Research Institute, Ottawa

All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER

NCT02084771 - Oral Salt and Water to Prevent Contrast Nephropathy | Biotech Hunter | Biotech Hunter